Retractable Technologies, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Retractable Technologies, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Cushion Ratio: Cash, after subtracting all debt, is 2.1 times its market value (net cash). Higher than 95% of Healthcare companies in United States.
- Cash Locked Ratio: For every $100 of sales, $49 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $32 tied up three years earlier. More money tied up than 91% of Healthcare companies in United States.
- Steadiness Ratio: Sales grew in 1 of the last 3 years; profit grew in 0 of 3. Less steady than 86% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-5.6×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Higher than 55% of Healthcare companies in United States.
Cash Locked Ratio
$49For every $100 of sales, $49 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $32 tied up three years earlier.
More money tied up than 91% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
1/3 · 0/3Sales grew in 1 of the last 3 years; profit grew in 0 of 3.
Less steady than 86% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales fell 60%
Sales fell 60% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-60% / -27%In 3 years sales changed by -60% while total assets changed by -27%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
-19.3×Operating cash was negative last year, while some debt falls due within a year.
Lower than 54% of Healthcare companies in United States.
Cash Cushion Ratio
2.1× cashCash, after subtracting all debt, is 2.1 times its market value (net cash).
Higher than 95% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Retractable Technologies, Inc. made a loss over the last year. Retractable Technologies, Inc. owes $0.49 for every $1 it owns. Retractable Technologies, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossRetractable Technologies, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
0.24The share price is 0.24 times Retractable Technologies, Inc.'s book value per share, lower than 97% of Healthcare companies in United States.
Market cap
$17 MThe total market value of all of Retractable Technologies, Inc.'s shares at today's price (share price × number of shares), smaller than 83% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
$73 MWhat Retractable Technologies, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$2.43Net worth divided by the number of shares. The share price of $0.58 is 0.2 times this, which is the P/B above.
Return on equity (ROE)
-4.5%Retractable Technologies, Inc. lost 4.5% of its shareholders' money over the last year, higher than 73% of Healthcare companies in United States.
Owes vs Owns
0.49×Retractable Technologies, Inc. owes $0.49 for every $1 it owns (low), higher than 54% of Healthcare companies in United States.
Dividend yield
NoneRetractable Technologies, Inc. does not currently pay a dividend.
Revenue growth
+16%Revenue rose 16% in the year to Dec 2025, and shrank 26% a year on average over 3 years.
Profit growth
LossRetractable Technologies, Inc. made a loss in each of the last two years.
Profit margin
-32.8%Retractable Technologies, Inc. lost $33 for every $100 of revenue.
Interest cover
Not coveredRetractable Technologies, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net cashRetractable Technologies, Inc. held $36 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Retractable Technologies, Inc.: $17 M ÷ $73 M (30 Jun 2026) = 0.2.
What is Retractable Technologies, Inc.'s return on equity?
Retractable Technologies, Inc. lost 4.5% of its shareholders' money over the last year, higher than 73% of Healthcare companies in United States.
How much does Retractable Technologies, Inc. owe compared with what it owns?
Retractable Technologies, Inc. owes $0.49 for every $1 it owns (low), higher than 54% of Healthcare companies in United States.
Does Retractable Technologies, Inc. pay a dividend?
No. Retractable Technologies, Inc. does not currently pay a dividend.
Is Retractable Technologies, Inc.'s revenue growing?
Revenue rose 16% in the year to Dec 2025, and shrank 26% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.